Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Bile Duct Neoplasms 1

Interventions

tivozanib 2 durvalumab 2 Specimen Handling 2 Magnetic Resonance Spectroscopy 2 Gemcitabine 2 Cisplatin 2 olaparib 1 atezolizumab 1 Stents 1 Oxaliplatin 1 Nivolumab 1 Leucovorin 1 Ipilimumab 1 Folfox protocol 1 Fluorouracil 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Bile Duct Neoplasms × Stents × 30 days × Clear all

NCT06274879 2026-05-26

Ablatio

Insel Gruppe AG, University Hospital Bern

Phase 2 Recruiting

Gastrointestinal

Bile Duct Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡